Entities / Company
Bruker.
American company
- Reports this week
- 0
- Active events
- 1
- Connections
- 104
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Bruker and Azenta, both healthcare companies, were compared on October 10, 2026.Some support1 report
-
Scott Bessent's call on August 23, 2025, amplified rate reduction sentiment, while Jerome Powell's comments spurred market uplift for Bruker.Some support3 reports
-
Trump's pledge to unleash oil and gas benefits certain stocks.Some support44 reports4 developments inside
-
Trump's tariff plan caused markets to tank, affecting company Flo.Some support79 reports12 developments inside
One to three months ago
-
UBS initiated coverage with a Neutral rating for Bruker on September 9, 2026.Some support1 report
-
GIGA and Bruker are evaluating RRP superconductors for power plants as fusion programs ramp up across the Americas.Some support1 report
-
Bruker is headquartered in Billerica, Massachusetts, and operates from its offices there.Some support2 reports2 developments inside
-
Atinary Technologies Inc. opened a self-driving lab in Boston and expanded collaboration with Bruker, establishing a joint lab near Basel.Some support1 report
-
Surging medical costs are impacting the health insurance sector, leading to industry-wide cost concerns affecting the stock market.Some support2 reports2 developments inside
-
Citigroup provides price targets and ratings for Bruker stock.Some support10 reports
Gone quiet
No new reports in 90+ days-
Bruker products received FDA-approved updates.Some support1 report
-
Barclays raised its price target and reiterated an Overweight rating for Bruker.Some support2 reports
-
Bruker shares are listed on Nasdaq, and Royal Bank of Canada has changed its position in the company, requiring SEC disclosure.Some support2 reports
-
Bruker stock is traded on the Nasdaq exchange.Some support1 report
-
Bruker made filings with the SEC regarding its stock disclosures on June 16, 2026.Some support2 reports
-
TD Cowen boosted its price target on Bruker.Some support1 report
-
Franklin Resources Inc. modified its stake in Bruker stock, requiring a filing with the SEC.Some support1 report
-
SPARK is identified as a mobility intelligence platform, and CMS penalties are currently impacting various U.S. hospitals.Some support2 reports1 development inside
-
Bruker is noted as a high-growth technology company.Some support2 reports
-
Tariffs and uncertainty, coupled with slow stimulus activity in China, are delaying biopharma investments.Some support2 reports6 developments inside
-
Stifel maintained a 'hold' recommendation for Bruker stock on July 23, 2025.Some support1 report
-
Bruker acquired majority stake in RECIPE on July 2, 2025, and the RECIPE kits were integrated into the Bruker system.Speculative1 report
-
Baidu and Bruker received downward earnings estimate revisions on June 23, 2025.Speculative1 report
-
A market rally occurred on August 13, 2025, driven by positive inflation data, involving Viatris, Bruker, Sotera Health Company, Align Technology, and Omnicell.Some support1 report
-
Patent litigation between Bruker and 10X Genomics was resolved via a global settlement requiring quarterly payments and royalties.Speculative1 report
-
AbCellera and Bruker are involved in ongoing multi-patent infringement litigation.Speculative1 report
-
INSIGHT system was identified as a metrology solution.Speculative2 reports
-
Thermo Fisher Scientific, Bruker, and Humana are highlighted for their contributions to scientific instruments, healthcare, and Medicare Advantage markets.Speculative1 report
-
Natera, a global diagnostics company, is involved in a business context with Bruker, which develops solutions for the US and distributes scientific instruments across Europe.Some support2 reports
-
Bruker, which develops high-performance scientific instruments, and WillScot, which provides temporary spaces for construction sites, are impacted by the market selloff triggered by Trump's April 2025 tariff bombshell.Some support1 report1 development inside
-
Bruker used a PIN for conference call registration on July 21, 2025.Some support1 report
-
Bruker and Humana are facing soft demand from academic institutions and a slowdown in the biopharma market.Some support2 reports
-
Bruker, Mettler-Toledo, and Thermo Fisher Scientific operate in the research tools and consumables segment.Some support3 reports1 development inside
-
Bruker reported that Germany contributed 7.4% of its total revenue in August 2025.Some support2 reports
-
Frank Laukien was appointed as the CEO of Bruker on August 13, 2025.Well supported4 reports
-
Bruker reported a 1.2% year-over-year decrease in revenues from its European segment, BSI.Some support2 reports1 development inside
-
BSI is one of Bruker's reporting segments. Calid and Nano are components of the BSI segment.Some support1 report
-
Rate cut speculation on August 14, 2025, benefited growth sectors, including healthcare companies like Clover Health, Surgery Partners, Illumina, and Bruker.Some support2 reports
-
Waters Corporation outperformed Bruker in recent quarterly reports.Some support1 report
-
J.P. Morgan & Co., Bruker, BofA Securities, and PNC Capital Markets LLC acted as joint book-running managers for an offering.Some support1 report
-
JPMorgan Chase and Bank of America are acting as underwriters for Bruker's stock issue, which is being used to retire company debt.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Bruker this week
News at the entities that move Bruker most-
SEC StructuralLaser Photonics Corporation hired Tim Peterman as Chief Financial Officer and engaged CBIZ for financial reporting consulting.Moves Bruker
-
Securities and Exchange Commission StructuralNYSE and Nasdaq plan to expand trading hours and file updated rules with the SEC.Moves Bruker
-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves Bruker
-
BioPharma OperationalCitigroup reiterated a positive rating on BioPharma on October 7, 2026.Moves Bruker
-
Citigroup OperationalCitigroup upgraded Next plc to a buy rating, while Santander and Morgan Stanley also issued rating updates on the company.Moves Bruker
-
TD Cowen Mentioned togetherTD Cowen upgraded Maze Therapeutics shares to a strong-buy rating, with coverage reported by MarketBeat.Moves Bruker
Connections
The 27 strongest of 104, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
BSI Structural
BSI operates as a formal reporting segment within the business structure of Bruker Corporation.
-
Frank Laukien Structural
Frank Laukien serves as the CEO of Bruker.
-
SEC Structural
Bruker operates under the formal filing and disclosure mandates of the U.S. Securities and Exchange Commission.
-
Securities and Exchange Commission Structural
Bruker is required to file various regulatory reports, including 13F filings, with the U.S. Securities and Exchange Commission.
-
AbCellera Structural
AbCellera is linked to Bruker via a subsidiary relationship, while also being involved in patent infringement litigation.
-
Nasdaq Structural
Bruker is a publicly traded company whose shares are listed on the Nasdaq exchange.
-
10X Genomics Structural
A and B resolved a patent dispute via a global settlement requiring ongoing royalties and quarterly payments.
-
BioPharma Operational
BioPharma market demand and conditions directly influence the performance of Bruker's BioSpin segment.
Show all 27 connections
-
National Institutes of Health Operational
NIH includes Bruker instruments in its grant applications, indicating a functional procurement relationship.
-
Royal Bank of Canada Transactional
Royal Bank of Canada has taken and boosted its investment holdings in Bruker stock.
-
FDA Structural
Bruker's products are subject to regulatory review and approval by the FDA.
-
Citigroup Operational
Citigroup actively provides financial ratings and price targets for Bruker stock.
-
Barclays Mentioned together
Barclays issued an Overweight rating and raised the price target for Bruker.
-
Leerink partners Mentioned together
Leerink Partners issued a price objective recommendation regarding Bruker.
-
GIGA Operational
GIGA and Bruker are involved in evaluating RRP superconductors for power plant applications.
-
Briefing.com Mentioned together
Briefing.com functions as a news aggregator reporting on the market coverage of Bruker by financial institutions like UBS.
-
MarketBeat Mentioned together
MarketBeat aggregates and tracks financial data, including stock performance and consensus ratings, for Bruker.
-
Massachusetts Shared context
Bruker operates from its headquarters located within the state of Massachusetts.
-
Japan Mentioned together
A market condition in China showing growth in academic and government orders was observed.
-
Americas Shared context
Bruker operates within the geographic and market context of the Americas.
-
Europe Shared context
Bruker operates and distributes its scientific solutions and instruments across the European market.
-
TD Cowen Mentioned together
TD Cowen provides investment banking analysis and research reports covering Bruker shares.
-
Billerica Shared context
Bruker is headquartered in Billerica, MA.
-
UBS Mentioned together
UBS initiated financial coverage of Bruker with a Neutral rating.
-
National Science Foundation Structural
Bruker instruments are included in and utilized within research projects funded by the National Science Foundation.
-
INSIGHT Mentioned together
The evidence describes INSIGHT as a metrology solution but does not detail its relationship with Bruker.
-
SPARK Mentioned together
The provided evidence does not describe any interaction or relationship between Bruker and SPARK.
History
Events by the month they beganOctober 2026
2 eventsSeptember 2026
2 eventsAugust 2026
1 eventShow 2 earlier months
July 2026
1 eventJune 2026
36 events- Scott Bessent's call on August 23, 2025, amplified rate reduction sentiment, while Jerome Powell's comments spurred market uplift for Bruker.
- Trump's pledge to unleash oil and gas benefits certain stocks.
- Trump's tariff plan caused markets to tank, affecting company Flo.
- Bruker is headquartered in Billerica, Massachusetts, and operates from its offices there.
- Surging medical costs are impacting the health insurance sector, leading to industry-wide cost concerns affecting the stock market.
- Bruker products received FDA-approved updates.
- Barclays raised its price target and reiterated an Overweight rating for Bruker.
- Bruker shares are listed on Nasdaq, and Royal Bank of Canada has changed its position in the company, requiring SEC disclosure.
- Bruker stock is traded on the Nasdaq exchange.
- Bruker made filings with the SEC regarding its stock disclosures on June 16, 2026.
- TD Cowen boosted its price target on Bruker.
- Franklin Resources Inc. modified its stake in Bruker stock, requiring a filing with the SEC.
- SPARK is identified as a mobility intelligence platform, and CMS penalties are currently impacting various U.S. hospitals.
- Bruker is noted as a high-growth technology company.
- Tariffs and uncertainty, coupled with slow stimulus activity in China, are delaying biopharma investments.
- Stifel maintained a 'hold' recommendation for Bruker stock on July 23, 2025.
- Bruker acquired majority stake in RECIPE on July 2, 2025, and the RECIPE kits were integrated into the Bruker system.
- Baidu and Bruker received downward earnings estimate revisions on June 23, 2025.
- A market rally occurred on August 13, 2025, driven by positive inflation data, involving Viatris, Bruker, Sotera Health Company, Align Technology, and Omnicell.
- Patent litigation between Bruker and 10X Genomics was resolved via a global settlement requiring quarterly payments and royalties.
- AbCellera and Bruker are involved in ongoing multi-patent infringement litigation.
- INSIGHT system was identified as a metrology solution.
- Thermo Fisher Scientific, Bruker, and Humana are highlighted for their contributions to scientific instruments, healthcare, and Medicare Advantage markets.
- Natera, a global diagnostics company, is involved in a business context with Bruker, which develops solutions for the US and distributes scientific instruments across Europe.
- Bruker, which develops high-performance scientific instruments, and WillScot, which provides temporary spaces for construction sites, are impacted by the market selloff triggered by Trump's April 2025 tariff bombshell.
- Bruker used a PIN for conference call registration on July 21, 2025.
- Bruker and Humana are facing soft demand from academic institutions and a slowdown in the biopharma market.
- Bruker, Mettler-Toledo, and Thermo Fisher Scientific operate in the research tools and consumables segment.
- Bruker reported that Germany contributed 7.4% of its total revenue in August 2025.
- Frank Laukien was appointed as the CEO of Bruker on August 13, 2025.
- Bruker reported a 1.2% year-over-year decrease in revenues from its European segment, BSI.
- BSI is one of Bruker's reporting segments. Calid and Nano are components of the BSI segment.
- Rate cut speculation on August 14, 2025, benefited growth sectors, including healthcare companies like Clover Health, Surgery Partners, Illumina, and Bruker.
- Waters Corporation outperformed Bruker in recent quarterly reports.
- J.P. Morgan & Co., Bruker, BofA Securities, and PNC Capital Markets LLC acted as joint book-running managers for an offering.
- JPMorgan Chase and Bank of America are acting as underwriters for Bruker's stock issue, which is being used to retire company debt.